X4 Pharmaceuticals, Inc. (XFOR)
4.055
+0.02
(+0.37%)
USD |
NASDAQ |
Aug 24, 16:00
4.055
0.00 (0.00%)
After-Hours: 20:00
X4 Pharmaceuticals 1 Year Total Returns (Daily) : 27.04% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 27.04% |
| August 20, 2026 | 43.93% |
| August 19, 2026 | 41.98% |
| August 18, 2026 | 69.08% |
| August 17, 2026 | 50.88% |
| August 14, 2026 | 34.39% |
| August 13, 2026 | 46.42% |
| August 12, 2026 | 66.28% |
| August 11, 2026 | 201.4% |
| August 10, 2026 | 185.2% |
| August 07, 2026 | 217.8% |
| August 06, 2026 | 163.9% |
| August 05, 2026 | 157.8% |
| August 04, 2026 | 171.5% |
| August 03, 2026 | 155.6% |
| July 31, 2026 | 136.9% |
| July 30, 2026 | 126.0% |
| July 29, 2026 | 107.8% |
| July 28, 2026 | 84.51% |
| July 27, 2026 | 116.5% |
| July 24, 2026 | 110.4% |
| July 23, 2026 | 166.0% |
| July 22, 2026 | 148.0% |
| July 21, 2026 | 141.2% |
| July 20, 2026 | 157.3% |
| Date | Value |
|---|---|
| July 17, 2026 | 156.4% |
| July 16, 2026 | 152.0% |
| July 15, 2026 | 165.3% |
| July 14, 2026 | 171.6% |
| July 13, 2026 | 183.2% |
| July 10, 2026 | 180.9% |
| July 09, 2026 | 138.6% |
| July 08, 2026 | 137.8% |
| July 07, 2026 | 133.8% |
| July 06, 2026 | 113.2% |
| July 02, 2026 | 108.6% |
| July 01, 2026 | 119.6% |
| June 30, 2026 | 145.8% |
| June 29, 2026 | 131.1% |
| June 26, 2026 | 101.0% |
| June 25, 2026 | 89.10% |
| June 24, 2026 | 77.83% |
| June 23, 2026 | 65.29% |
| June 22, 2026 | 54.31% |
| June 18, 2026 | 49.65% |
| June 17, 2026 | 47.81% |
| June 16, 2026 | 47.99% |
| June 15, 2026 | 44.68% |
| June 12, 2026 | 31.15% |
| June 11, 2026 | 21.06% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Sarepta Therapeutics, Inc. | -6.33% |
| Arrowhead Pharmaceuticals, Inc. | 319.8% |
| Oncolytics Biotech, Inc. | -16.52% |
| Sangamo Therapeutics, Inc. | -75.17% |
| Anixa Biosciences, Inc. | 25.76% |